Novo Nordisk (NVO) Financial Analysis & Valuation | Quarter Chart

Novo Nordisk (NVO)

NVO
Price: $48.34
Fair Value: 🔒
🔒score
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obe... more
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufactu... more
Description Shares
Market Cap$214.81BExchangeNYSE
SectorHealthcareIndustryBiotechnology
CountryDKCEOMaziar Mike Doustdar
IPO Date1981-04-30CAGR0.11%
Employees77,406Websitewww.novonordisk.com
Div. Yield3.67%Payout Ratio0.42%
Buy Back Yield1.12%Total Yield4.79%
NVO chart loading...
Fundamentals Technicals
Enterprise Value$1196.04BP/E Ratio12
Forward P/E2.28PEG Ratio0.17
P/S Ratio4.53P/B Ratio7.32
P/CF Ratio12.53P/FCF Ratio47.89
EPS$4.03EPS Growth 1Y16.79%
EPS Growth 3Y102.89%EPS Growth 5Y197.61%
Revenue Growth 1Y8.13%Gross Margin0.82%
Operating Margin0.45%Profit Margin0.37%
ROE0.66%ROA0.22%
ROCE0.44%Current Ratio0.79
Quick Ratio0.56Cash Ratio0.09
Debt/Equity0.72Interest Coverage29.15
Altman Z Score4.13Piotroski Score5

View Novo Nordisk financial charts →